Polycaprolactone/Gelatin/Hyaluronic Acid Electrospun Scaffolds to Mimic Glioblastoma Extracellular Matrix.
3D extracellular matrix
gelatin
glioblastoma tumor model
hyaluronic acid
nanofiber
polycaprolactone
Journal
Materials (Basel, Switzerland)
ISSN: 1996-1944
Titre abrégé: Materials (Basel)
Pays: Switzerland
ID NLM: 101555929
Informations de publication
Date de publication:
11 Jun 2020
11 Jun 2020
Historique:
received:
23
04
2020
revised:
30
05
2020
accepted:
02
06
2020
entrez:
18
6
2020
pubmed:
18
6
2020
medline:
18
6
2020
Statut:
epublish
Résumé
Glioblastoma (GBM), one of the most malignant types of human brain tumor, is resistant to conventional treatments and is associated with poor survival. Since the 3D extracellular matrix (ECM) of GBM microenvironment plays a significant role on the tumor behavior, the engineering of the ECM will help us to get more information on the tumor behavior and to define novel therapeutic strategies. In this study, polycaprolactone (PCL)/gelatin(Gel)/hyaluronic acid(HA) composite scaffolds with aligned and randomly oriented nanofibers were successfully fabricated by electrospinning for mimicking the extracellular matrix of GBM tumor. We investigated the effect of nanotopography and components of fibers on the mechanical, morphological, and hydrophilic properties of electrospun nanofiber as well as their biocompatibility properties. Fourier transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC) have been used to investigate possible interactions between components. The mean fiber diameter in the nanofiber matrix was increased with the presence of HA at low collector rotation speed. Moreover, the rotational velocity of the collector affected the fiber diameters as well as their homogenous distribution. Water contact angle measurements confirmed that hyaluronic acid-incorporated aligned nanofibers were more hydrophilic than that of random nanofibers. In addition, PCL/Gel/HA nanofibrous scaffold (7.9 MPa) exhibited a significant decrease in tensile strength compared to PCL/Gel nanofibrous mat (19.2 MPa). In-vitro biocompatibilities of nanofiber scaffolds were tested with glioblastoma cells (U251), and the PCL/Gel/HA scaffolds with random nanofiber showed improved cell adhesion and proliferation. On the other hand, PCL/Gel/HA scaffolds with aligned nanofiber were found suitable for enhancing axon growth and elongation supporting intracellular communication. Based on these results, PCL/Gel/HA composite scaffolds are excellent candidates as a biomimetic matrix for GBM and the study of the tumor.
Identifiants
pubmed: 32545241
pii: ma13112661
doi: 10.3390/ma13112661
pmc: PMC7321639
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : The Scientific and Technological Research Council of Turkey
ID : FEN-C-DRP-110718-0412
Références
Colloids Surf B Biointerfaces. 2018 Oct 1;170:152-162
pubmed: 29902729
Mol Pharm. 2014 Jul 7;11(7):2115-25
pubmed: 24712441
Biomaterials. 2008 Dec;29(34):4532-9
pubmed: 18757094
Int J Nanomedicine. 2014 May 13;9:2335-44
pubmed: 24872696
Tissue Eng Part A. 2015 Oct;21(19-20):2572-82
pubmed: 26161688
J Biomed Mater Res A. 2014 Sep;102(9):3130-9
pubmed: 24132994
Biomacromolecules. 2006 Jul;7(7):2243-7
pubmed: 16827594
Adv Healthc Mater. 2017 Nov;6(22):
pubmed: 28941173
Mater Sci Eng C Mater Biol Appl. 2015 Jan;46:348-58
pubmed: 25491997
J Biomed Mater Res A. 2014 Jul;102(7):2220-9
pubmed: 23913820
ACS Appl Mater Interfaces. 2013 Oct 9;5(19):9276-84
pubmed: 24010546
Mater Sci Eng C Mater Biol Appl. 2017 Feb 1;71:901-908
pubmed: 27987787
Biomaterials. 2011 Nov;32(31):7932-40
pubmed: 21820735
Mater Sci Eng C Mater Biol Appl. 2013 Apr 1;33(3):1228-35
pubmed: 23827565
Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:324-332
pubmed: 28575991
Biomaterials. 2014 Nov;35(34):9395-405
pubmed: 25134855
Biomaterials. 2013 Jul;34(21):5181-90
pubmed: 23601662
Colloids Surf B Biointerfaces. 2017 Nov 1;159:7-15
pubmed: 28778063
Adv Healthc Mater. 2018 Aug;7(15):e1800295
pubmed: 29893067
Mater Sci Eng C Mater Biol Appl. 2017 Jun 1;75:445-453
pubmed: 28415484
Interface Focus. 2012 Jun 6;2(3):278-91
pubmed: 23741606
Colloids Surf B Biointerfaces. 2016 Oct 1;146:632-41
pubmed: 27429297
Biomacromolecules. 2016 Oct 10;17(10):3172-3187
pubmed: 27629596
Mater Sci Eng C Mater Biol Appl. 2014 Nov;44:183-90
pubmed: 25280695
Mater Sci Eng C Mater Biol Appl. 2016 Dec 1;69:380-7
pubmed: 27612726
Colloids Surf B Biointerfaces. 2018 Dec 1;172:718-727
pubmed: 30245297
Biomaterials. 2013 Dec;34(38):10143-50
pubmed: 24075410
Macromol Biosci. 2017 Aug;17(8):
pubmed: 28379642
Acta Biomater. 2016 Jun;37:131-42
pubmed: 27063493
Adv Healthc Mater. 2016 Dec;5(24):3173-3181
pubmed: 27805789
Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:218-229
pubmed: 28575978
J Biomater Sci Polym Ed. 2016 Jun;27(9):824-38
pubmed: 27044505
Front Mater. 2018 Jun;5:
pubmed: 30581816
Int J Biol Macromol. 2016 Dec;93(Pt B):1539-1548
pubmed: 27185071
PLoS One. 2018 Oct 4;13(10):e0204865
pubmed: 30286133
Sci Rep. 2016 Mar 29;6:23761
pubmed: 27021221
J Biomed Mater Res B Appl Biomater. 2005 Jan 15;72(1):156-65
pubmed: 15389493
Mater Sci Eng C Mater Biol Appl. 2020 Feb;107:110296
pubmed: 31761169